https://wuxibiologics.com

WuXi BiologicsA leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturingWuXi Biologics WuXi Biologics Offering End-to-End Solutions About Us About Us Company Vision & Mission Culture History & Awards Business Ethics Leadership Scientific Advisory Board Locations & Facilities Services & Capabilities About Us Production Systems Mammalian$Our expertise spans discovery, development, and cGMP manufacture of biologics from mammalian cell culture. Leveraging 6 discovery platforms, a top-tier CMC development team, and an extensive supply chain, we deliver seamless programs for all your biologics drug development needs. Back Mammalian-Derived Product Services$A true single-source provider from concept to commercialization for biologics produced from mammalian cell culture.Mammalian-Derived Product ServicesA true single-source provider from concept to commercialization for biologics produced from mammalian cell culture.Learn more Product types we support: Monoclonal Antibodies$Discover information about the various drug development services we provide for this product typeMonoclonal AntibodiesDiscover information about the various drug development services we provide for this product typeLearn more Bispecific & Multispecific Antibodies$Discover information about the various drug development services we provide for this product typeBispecific & Multispecific AntibodiesDiscover information about the various drug development services we provide for this product typeLearn more Fc-Fusion Proteins$Discover information about the various drug development services we provide for this product typeFc-Fusion ProteinsDiscover information about the various drug development services we provide for this product typeLearn more Antibody Fragments$Discover information about the various drug development services we provide for this product typeAntibody FragmentsDiscover information about the various drug development services we provide for this product typeLearn more Recombinant Proteins / Enzymes / Cytokines$Discover information about the various drug development services we provide for this product typeRecombinant Proteins / Enzymes / CytokinesDiscover information about the various drug development services we provide for this product typeLearn more Non-Vaccine Viral Products$Discover information about the various drug development services we provide for this product typeNon-Vaccine Viral ProductsDiscover information about the various drug development services we provide for this product typeLearn more Antibody Drug Conjugates (ADCs)$Discover information about the various drug development services we provide for this product typeAntibody Drug Conjugates (ADCs)Discover information about the various drug development services we provide for this product typeLearn more Virus-Like Particles (VLPs)$Discover information about the various drug development services we provide for this product typeVirus-Like Particles (VLPs)Discover information about the various drug development services we provide for this product typeLearn more Subsidiaries Microbial$Comprehensive CMC development and cGMP manufacturing microbial fermentation platform. E. coli and yeast-based expression systems for the production of plasmid DNA and recombinant proteins. Back Microbial-Derived Product Services$High quality, expert services for biologics produced from microbial fermentation.Microbial-Derived Product ServicesHigh quality, expert services for biologics produced from microbial fermentation.Learn more Product types we support Antibody Fragments$Discover information about the various drug development services we provide for this product typeAntibody FragmentsDiscover information about the various drug development services we provide for this product typeLearn more Enzymes / Cytokines$Discover information about the various drug development services we provide for this product typeEnzymes / CytokinesDiscover information about the various drug development services we provide for this product typeLearn more Plasmid DNA (pDNA)$Discover information about the various drug development services we provide for this product typePlasmid DNA (pDNA)Discover information about the various drug development services we provide for this product typeLearn more Virus-Like Particles (VLPs)$Discover information about the various drug development services we provide for this product typeVirus-Like Particles (VLPs)Discover information about the various drug development services we provide for this product typeLearn more RNA / mRNA$Discover information about the various drug development services we provide for this product typeRNA / mRNADiscover information about the various drug development services we provide for this product typeLearn more Subsidiaries Capabilities Research$Integrated Discovery Platform From Concept to IND Back Integrated Discovery Service$Industry-leading expertise, state-of-the-art facilities, and multiple antibody generation technology platforms for the discovery of novel monoclonal, bispecific and multispecific antibodies, immunocytokines and other biologics.Integrated Discovery ServiceIndustry-leading expertise, state-of-the-art facilities, and multiple antibody generation technology platforms for the discovery of novel monoclonal, bispecific and multispecific antibodies, immunocytokines and other biologics.Learn more Protein Sciences$Specializing in monoclonal, bispecific, and multi-specific antibodies, fusion-proteins, cytokines, enzymes, and other biologics, we offer our customers high productivity and high quality antibody and protein production services for all of your research needs.Protein SciencesSpecializing in monoclonal, bispecific, and multi-specific antibodies, fusion-proteins, cytokines, enzymes, and other biologics, we offer our customers high productivity and high quality antibody and protein production services for all of your research needs.Learn more Subsidiaries Development$Utilizing one of the world’s largest and most experienced development teams, we have the resources, technologies and expertise to drive your program toward IND and BLA in the most efficient and cost-effective manner. Back Protein Sciences$We unite expert protein engineering capabilities with our high throughput and high productivity research-scale protein production services to enable all of your R&D initiatives.Protein SciencesWe unite expert protein engineering capabilities with our high throughput and high productivity research-scale protein production services to enable all of your R&D initiatives.Learn more Cell Line Engineering$Provided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading timelines for cell line engineering and strain development across a wide range of biotherapeutics.Cell Line EngineeringProvided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading timelines for cell line engineering and strain development across a wide range of biotherapeutics.Learn more Analytical Sciences$Our extensive analytical testing services offer top-tier expertise in method development for in-process, release, and stability assays, and support of cell line, process, and formulation development activities, product characterization, developability assessments and other key IND- and BLA-enabling studies.Analytical SciencesOur extensive analytical testing services offer top-tier expertise in method development for in-process, release, and stability assays, and support of cell line, process, and formulation development activities, product characterization, developability assessments and other key IND- and BLA-enabling studies.Learn more Process Development & Scale Up$Multiple upstream and downstream PD labs facilitate the establishment and scale-up of fed-batch, intensified fed-batch, and continuous manufacturing approaches for diverse biotherapeutic modalities in both early and late-stage development.Process Development & Scale UpMultiple upstream and downstream PD labs facilitate the establishment and scale-up of fed-batch, intensified fed-batch, and continuous manufacturing approaches for diverse biotherapeutic modalities in both early and late-stage development.Learn more Formulation & Drug Product Development$We provide advanced drug product development services spanning biologics, vaccines, and small molecules, with expertise in formulating clinical and commercial products in liquid, frozen, and lyophilized forms, compatible with various container closure systems such as vials, prefilled syringes, and other combination product types.Formulation & Drug Product DevelopmentWe provide advanced drug product development services spanning biologics, vaccines, and small molecules, with expertise in formulating clinical and commercial products in liquid, frozen, and lyophilized forms, compatible with various container closure systems such as vials, prefilled syringes, and other combination product types.Learn more Cell Banking & Characterization$Offering in-house, one-stop cell banking and cell line characterization services, compliant with global GMP regulations and ICH guidelines, we operate over 20 cGMP cell banking suites ensuring capacity availability and timely execution of this critical CMC development activity.Cell Banking & CharacterizationOffering in-house, one-stop cell banking and cell line characterization services, compliant with global GMP regulations and ICH guidelines, we operate over 20 cGMP cell banking suites ensuring capacity availability and timely execution of this critical CMC development activity.Learn more Viral Clearance$Our extensive experience and expertise, along with EMA, ISO (CNAS), and CMA-certified laboratories, and exceptional track record for IND- and BLA-enabling viral clearance study acceptance by global regulatory agencies, form the cornerstones for this pivotal aspect of any CMC development program.Viral ClearanceOur extensive experience and expertise, along with EMA, ISO (CNAS), and CMA-certified laboratories, and exceptional track record for IND- and BLA-enabling viral clearance study acceptance by global regulatory agencies, form the cornerstones for this pivotal aspect of any CMC development program.Learn more Regulatory Support$Our experienced regulatory affairs team supports drug filing and registration with over 370 INDs/CTAs, 20+ BLAs/MAAs/NDAs/EUAs, and 150 Module 3 CMC packages since 2015.Regulatory SupportOur experienced regulatory affairs team supports drug filing and registration with over 370 INDs/CTAs, 20+ BLAs/MAAs/NDAs/EUAs, and 150 Module 3 CMC packages since 2015.Learn more Subsidiaries Manufacturing$Multiple state-of-the-art, premier quality cGMP clinical- and commercial-scale drug substance (DS) and drug product (DP) facilities across four countries for the production of a wide array of biologics from both mammalian and microbial expression systems. Back Clinical DS GMP Manufacturing$Operating multiple high-quality, state-of-the-art clinical-scale cGMP facilities for biologics drug substance (DS) production utilizing both mammalian and microbial expression systems.Clinical DS GMP ManufacturingOperating multiple high-quality, state-of-the-art clinical-scale cGMP facilities for biologics drug substance (DS) production utilizing both mammalian and microbial expression systems.Learn more Clinical DP GMP Manufacturing$Multiple, highly flexible clinical-scale drug product (DP) manufacturing facilities for the formulation, fill, labelling and packaging of biologics and parenterals under Current Good Manufacturing Practice (cGMP) conditions as defined by global regulatory agencies.Clinical DP GMP ManufacturingMultiple, highly flexible clinical-scale drug product (DP) manufacturing facilities for the formulation, fill, labelling and packaging of biologics and parenterals under Current Good Manufacturing Practice (cGMP) conditions as defined by global regulatory agencies.Learn more Commercial DS GMP Manufacturing$We provide a global dual source manufacturing network that employs multiple large-scale drug substance (DS) GMP manufacturing facilities for the production of biologics utilizing our world-class operations and regulatory agency-approved quality systems.Commercial DS GMP ManufacturingWe provide a global dual source manufacturing network that employs multiple large-scale drug substance (DS) GMP manufacturing facilities for the production of biologics utilizing our world-class operations and regulatory agency-approved quality systems.Learn more Commercial DP GMP Manufacturing$Multiple large-scale drug product (DP) manufacturing facilities located across the globe for the high-quality formulation, fill, labelling and packaging of biologics, parenterals and placebo into a wide array of container closure systems.Commercial DP GMP ManufacturingMultiple large-scale drug product (DP) manufacturing facilities located across the globe for the high-quality formulation, fill, labelling and packaging of biologics, parenterals and placebo into a wide array of container closure systems.Learn more Subsidiaries Testing$We provide extensive expertise for in-process, characterization, release and stability method development and testing either in support of our integrated biologics development platforms or as standalone projects. Our wide-range of analytical and biosafety testing Centers of Excellence and regulatory agency-approved quality control (QC) laboratories are the backbone of every service we provide our clients. Back Biosafety Testing$High quality, in-house and EMA, ISO (CNAS) and CMA certified biosafety testing facilities for adventitious agent screening of raw materials, cell lines and unprocessed bulk along with our extensive viral clearance capabilities is available to provide our clients with a single-source biosafety testing service offering.Biosafety TestingHigh quality, in-house and EMA, ISO (CNAS) and CMA certified biosafety testing facilities for adventitious agent screening of raw materials, cell lines and unprocessed bulk along with our extensive viral clearance capabilities is available to provide our clients with a single-source biosafety testing service offering.Learn more Analytical Testing$We offer an extensive array of assay development and analytical testing services, including bioassay development and forensic investigation analysis, along with other key characterization and IND and BLA-enabling studies throughout the various phases of drug development – all tailored for your unique product and project needs.Analytical TestingWe offer an extensive array of assay development and analytical testing services, including bioassay development and forensic investigation analysis, along with other key characterization and IND and BLA-enabling studies throughout the various phases of drug development – all tailored for your unique product and project needs.Learn more Centers of Excellence (CoE)$Our CoEs support projects with specialized testing throughout the product lifecycle, expediting project timelines and ensuring analytical readiness for commercialization.Centers of Excellence (CoE)Our CoEs support projects with specialized testing throughout the product lifecycle, expediting project timelines and ensuring analytical readiness for commercialization.Learn more Global Quality Control (QC)$Regulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Global Quality Control (QC)Regulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Learn more Subsidiaries Quality Quality & Regulatory$We provide world-class quality systems, harmonized across our global manufacturing sites and approved by multiple global regulatory agencies, including the U.S. FDA, EMA, NMPA, PMDA, MFDS, HSA, ANVISA and Health Canada for the production and testing of a wide array of biologics. Back Global Compliance$Oversees global quality system and audit, IT quality, internal compliance, and risk analytics functions. This team embeds quality and compliance across the entire organization to ensure the products we manufacture are of the highest efficacy and safety standards and in line with your expectations.Global ComplianceOversees global quality system and audit, IT quality, internal compliance, and risk analytics functions. This team embeds quality and compliance across the entire organization to ensure the products we manufacture are of the highest efficacy and safety standards and in line with your expectations.Learn more Quality Assurance$Global systems meet regulatory standards, ingrained commitment to quality from CEO to employees, harmonized QA across worldwide sites for biologics and vaccines production.Quality AssuranceGlobal systems meet regulatory standards, ingrained commitment to quality from CEO to employees, harmonized QA across worldwide sites for biologics and vaccines production.Learn more Quality Control$Regulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Quality ControlRegulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Learn more Regulatory Affairs$Our experienced regulatory affairs team supports our client’s CMC dossier, drug filing and registration needs. Since 2015 this team has supported 550+ INDs, CTAs, BLAs, MAAs, NDAs and EUAs, and written 200+ Module 3 CMC packages on behalf of our global clients.Regulatory AffairsOur experienced regulatory affairs team supports our client’s CMC dossier, drug filing and registration needs. Since 2015 this team has supported 550+ INDs, CTAs, BLAs, MAAs, NDAs and EUAs, and written 200+ Module 3 CMC packages on behalf of our global clients.Learn more Subsidiaries Featured Platforms Integrated Platforms$Comprehensive, high-quality, end-to-end solutions driving efficiency, decreasing time to clinic and reducing project risks from concept to commercialization. Back Target to Lead$Providing expertise, highly efficient tailored solutions, state-of-the-art technologies and world-class facilities for the engineering, generation, and optimization of antibodies and other biologics from target identification to final lead selection.Target to LeadProviding expertise, highly efficient tailored solutions, state-of-the-art technologies and world-class facilities for the engineering, generation, and optimization of antibodies and other biologics from target identification to final lead selection.Learn more DNA to IND$Providing industry-leading 10-month (or less) DNA to IND timeline for biologics by leveraging our single-source, high-quality, and well-vetted development platform across all CMC activities.DNA to INDProviding industry-leading 10-month (or less) DNA to IND timeline for biologics by leveraging our single-source, high-quality, and well-vetted development platform across all CMC activities.Learn more IND to BLA$Streamlined late-phase development and manufacturing services, ensuring BLA filing in 15 months or less, with global commercialization support through our highly-vetted development platforms.IND to BLAStreamlined late-phase development and manufacturing services, ensuring BLA filing in 15 months or less, with global commercialization support through our highly-vetted development platforms.Learn more Subsidiaries Discovery Technologies$A full spectrum of discovery services and technologies for the engineering, generation, characterization, optimization and selection of high-potency novel antibody therapeutics. Back Bispecific & Multispecific Antibodies – WuXiBody™$The WuXiBody™ platform for the generation of bispecific (bsAb) and multispecific (msAb) antibodies speeds up drug development by 6-18 months, cuts production costs, and enables flexible assembly of mAb sequence pairs into various formats with different valency.Bispecific & Multispecific Antibodies - WuXiBody™The WuXiBody™ platform for the generation of bispecific (bsAb) and multispecific (msAb) antibodies speeds up drug development by 6-18 months, cuts production costs, and enables flexible assembly of mAb sequence pairs into various formats with different valency.Learn more Advanced Hybridoma Platform – WuXiHybrid™$Using advanced technologies to generate diverse monoclonal antibodies (mAb) for various targets. Our experienced scientists overcome technical challenges to deliver high-quality mAbs to our clients worldwide.Advanced Hybridoma Platform - WuXiHybrid™Using advanced technologies to generate diverse monoclonal antibodies (mAb) for various targets. Our experienced scientists overcome technical challenges to deliver high-quality mAbs to our clients worldwide.Learn more Naive Phage Display Library – WuXiLiAb™$Offering high-quality phage display library construction and customized library selection and screening services via our WuXiLiAb® human naïve / synthetic phage display libraries, VHH naïve / humanized VHH synthetic libraries and antibody immune libraries.Naive Phage Display Library - WuXiLiAb™Offering high-quality phage display library construction and customized library selection and screening services via our WuXiLiAb® human naïve / synthetic phage display libraries, VHH naïve / humanized VHH synthetic libraries and antibody immune libraries.Learn more VHH-based Multispecific Antibody Platform – SDARBody™$Novel technology platform to enable the development of multispecific proteins. Highly flexible platform capable of generating multispecific antibody and protein therapeutics with high affinity, low immunogenicity risk and excellent developability characteristics.VHH-based Multispecific Antibody Platform - SDARBody™Novel technology platform to enable the development of multispecific proteins. Highly flexible platform capable of generating multispecific antibody and protein therapeutics with high affinity, low immunogenicity risk and excellent developability characteristics.Learn more ScFv-based BsAb & MsAb Antibody Platform – SKYBody™$An innovative scFv (single-chain fragment variables)-based platform for the generation of bispecific or multispecific antibodies from nearly any sequence pair. The platform significantly improves scFv stability providing bsAbs and msAbs with strong developability characteristics.ScFv-based BsAb & MsAb Antibody Platform - SKYBody™An innovative scFv (single-chain fragment variables)-based platform for the generation of bispecific or multispecific antibodies from nearly any sequence pair. The platform significantly improves scFv stability providing bsAbs and msAbs with strong developability characteristics.Learn more VAST-B Single B-Cell Antibody Discovery Platform$An advanced, high speed, high throughput and high resolution antibody screening strategy using Beacon® technology for the rapid discovery of monoclonal antibodies (mAb) from any host species.VAST-B Single B-Cell Antibody Discovery PlatformAn advanced, high speed, high throughput and high resolution antibody screening strategy using Beacon® technology for the rapid discovery of monoclonal antibodies (mAb) from any host species.Learn more Subsidiaries Development Technologies$Cutting-edge bioprocessing platforms and technologies designed to enable high-quality biologics to enter clinical trials faster, more efficiently and more cost-effectively. Back Ultra-Intensified Fed-batch platform – WuXiUI™$Ultra-intensified fed-batch bioprocessing platform utilizes an intermittent perfusion approach to achieve 3-6-fold higher productivity and 60 – 80% reduction in manufacturing cost of goods compared to traditional fed-batch processes.Ultra-Intensified Fed-batch platform - WuXiUI™Ultra-intensified fed-batch bioprocessing platform utilizes an intermittent perfusion approach to achieve 3-6-fold higher productivity and 60 – 80% reduction in manufacturing cost of goods compared to traditional fed-batch processes.Learn more Rapid Research Material Generation – WuXian™$Custom protein generation services, producing high-quality, research-grade proteins/antibodies by using our industry-leading team of cell culture, purification and analytical experts and high-throughput, cost-effective production technologies.Rapid Research Material Generation - WuXian™Custom protein generation services, producing high-quality, research-grade proteins/antibodies by using our industry-leading team of cell culture, purification and analytical experts and high-throughput, cost-effective production technologies.Learn more Cell Line Development – WuXia™$Proven, high-yielding (up to 11 g/L) and high-quality cell line development platform, accepted by regulatory agencies worldwide.Cell Line Development - WuXia™Proven, high-yielding (up to 11 g/L) and high-quality cell line development platform, accepted by regulatory agencies worldwide.Learn more Continuous Bioprocessing – WuXiUP™$This ultra-high productivity continuous bioprocessing platform, achieves 5-15X greater productivity, delivering high-yield, quality drug products with flexibility and cost-effectiveness through intensified perfusion culture, continuous harvest and optional downstream continuous product capture step.Continuous Bioprocessing - WuXiUP™This ultra-high productivity continuous bioprocessing platform, achieves 5-15X greater productivity, delivering high-yield, quality drug products with flexibility and cost-effectiveness through intensified perfusion culture, continuous harvest and optional downstream continuous product capture step.Learn more ADC Development Platform – WuXiDAR4™$Our drug-to-antibody ratio and enrichment technology greatly enhances DAR4 (four payload molecules per mAb) percentage in the final ADC product and improves conjugation efficiency.ADC Development Platform - WuXiDAR4™Our drug-to-antibody ratio and enrichment technology greatly enhances DAR4 (four payload molecules per mAb) percentage in the final ADC product and improves conjugation efficiency.Learn more High Concentration & HTP DP Platform – WuXiHigh™$Advanced high throughput formulation platform for development of high concentration biologics drug products using distinctive viscosity reducers and synergistic excipient combinations to enhance formulation stability and reduce viscosity.High Concentration & HTP DP Platform - WuXiHigh™Advanced high throughput formulation platform for development of high concentration biologics drug products using distinctive viscosity reducers and synergistic excipient combinations to enhance formulation stability and reduce viscosity.Learn more Subsidiaries Manufacturing Technologies$Advanced biomanufacturing platforms empower our global healthcare partners to deliver biologics to the clinic and on to the market for the benefit of patients worldwide. Back Single-Use Bioreactors$We operate several of the world’s largest single-use bioreactor facilities for biologics manufacturing, leveraging the risk reduction, flexibility, cost-effectiveness, and eco-friendliness offered by these systems.Single-Use BioreactorsWe operate several of the world’s largest single-use bioreactor facilities for biologics manufacturing, leveraging the risk reduction, flexibility, cost-effectiveness, and eco-friendliness offered by these systems.Learn more Scale-Out Biomanufacturing$Helping to pioneer this biomanufacturing strategy for higher volume production, we can help you reduce risk and increase manufacturing flexibility across the entire product lifecycle by using multiple, same-scale bioreactors to meet clinical and market demand.Scale-Out BiomanufacturingHelping to pioneer this biomanufacturing strategy for higher volume production, we can help you reduce risk and increase manufacturing flexibility across the entire product lifecycle by using multiple, same-scale bioreactors to meet clinical and market demand.Learn more Robotic Aseptic Filling$Reducing manufacturing risk through the use of this fully programmable, robotic, gloveless, isolator-based technology for advanced aseptic drug product fill processing. These systems provide extensive flexibility to support complex fills across a wide range of biologics and container closure systems.Robotic Aseptic FillingReducing manufacturing risk through the use of this fully programmable, robotic, gloveless, isolator-based technology for advanced aseptic drug product fill processing. These systems provide extensive flexibility to support complex fills across a wide range of biologics and container closure systems.Learn more Continuous Manufacturing Process$Combining intensified perfusion culture (IPC) and continuous direct product capture (CDPC), and advanced equipment for increased productivity and cost reduction.Continuous Manufacturing ProcessCombining intensified perfusion culture (IPC) and continuous direct product capture (CDPC), and advanced equipment for increased productivity and cost reduction.Learn more Subsidiaries Animal Health Technologies$One-stop solution for superior animal health outcomes. Back Animal Health Technologies$We offer CMC-compliant, one-stop solution for animal health, to support taking drug substance and drug product from research to manufacturing.Animal Health TechnologiesWe offer CMC-compliant, one-stop solution for animal health, to support taking drug substance and drug product from research to manufacturing.Learn more Subsidiaries Sustainability About Us Sustainability Environmental Social Governance ESG Latest News ESG Report Careers About Us What We Value Proud Life Meet our people Experienced Professionals Employee Stories Worldwide Join us Job Opportunity Talent Pool Investors About Us Corporate Governance Financial Reports Announcements & Circulars Stock Information Investor Events Presentations & Webcasts Calendar Investor Day Investors Contact News & Resources About Us Press Releases Knowledge Center Events 中文 / CN Deutsch / DE 日本語 / JP 한글 / KR Contact Us 菜单 About Us Company Vision & Mission Culture History & Awards Business Ethics Leadership Scientific Advisory Board Locations & Facilities Services & Capabilities Production Systems Mammalian$Our expertise spans discovery, development, and cGMP manufacture of biologics from mammalian cell culture. Leveraging 6 discovery platforms, a top-tier CMC development team, and an extensive supply chain, we deliver seamless programs for all your biologics drug development needs. Mammalian-Derived Product Services$A true single-source provider from concept to commercialization for biologics produced from mammalian cell culture.Mammalian-Derived Product ServicesA true single-source provider from concept to commercialization for biologics produced from mammalian cell culture.Learn more Product types we support: Monoclonal Antibodies$Discover information about the various drug development services we provide for this product typeMonoclonal AntibodiesDiscover information about the various drug development services we provide for this product typeLearn more Bispecific & Multispecific Antibodies$Discover information about the various drug development services we provide for this product typeBispecific & Multispecific AntibodiesDiscover information about the various drug development services we provide for this product typeLearn more Fc-Fusion Proteins$Discover information about the various drug development services we provide for this product typeFc-Fusion ProteinsDiscover information about the various drug development services we provide for this product typeLearn more Antibody Fragments$Discover information about the various drug development services we provide for this product typeAntibody FragmentsDiscover information about the various drug development services we provide for this product typeLearn more Recombinant Proteins / Enzymes / Cytokines$Discover information about the various drug development services we provide for this product typeRecombinant Proteins / Enzymes / CytokinesDiscover information about the various drug development services we provide for this product typeLearn more Non-Vaccine Viral Products$Discover information about the various drug development services we provide for this product typeNon-Vaccine Viral ProductsDiscover information about the various drug development services we provide for this product typeLearn more Antibody Drug Conjugates (ADCs)$Discover information about the various drug development services we provide for this product typeAntibody Drug Conjugates (ADCs)Discover information about the various drug development services we provide for this product typeLearn more Virus-Like Particles (VLPs)$Discover information about the various drug development services we provide for this product typeVirus-Like Particles (VLPs)Discover information about the various drug development services we provide for this product typeLearn more Microbial$Comprehensive CMC development and cGMP manufacturing microbial fermentation platform. E. coli and yeast-based expression systems for the production of plasmid DNA and recombinant proteins. Microbial-Derived Product Services$High quality, expert services for biologics produced from microbial fermentation.Microbial-Derived Product ServicesHigh quality, expert services for biologics produced from microbial fermentation.Learn more Product types we support Antibody Fragments$Discover information about the various drug development services we provide for this product typeAntibody FragmentsDiscover information about the various drug development services we provide for this product typeLearn more Enzymes / Cytokines$Discover information about the various drug development services we provide for this product typeEnzymes / CytokinesDiscover information about the various drug development services we provide for this product typeLearn more Plasmid DNA (pDNA)$Discover information about the various drug development services we provide for this product typePlasmid DNA (pDNA)Discover information about the various drug development services we provide for this product typeLearn more Virus-Like Particles (VLPs)$Discover information about the various drug development services we provide for this product typeVirus-Like Particles (VLPs)Discover information about the various drug development services we provide for this product typeLearn more RNA / mRNA$Discover information about the various drug development services we provide for this product typeRNA / mRNADiscover information about the various drug development services we provide for this product typeLearn more Capabilities Research$Integrated Discovery Platform From Concept to IND Integrated Discovery Service$Industry-leading expertise, state-of-the-art facilities, and multiple antibody generation technology platforms for the discovery of novel monoclonal, bispecific and multispecific antibodies, immunocytokines and other biologics.Integrated Discovery ServiceIndustry-leading expertise, state-of-the-art facilities, and multiple antibody generation technology platforms for the discovery of novel monoclonal, bispecific and multispecific antibodies, immunocytokines and other biologics.Learn more Protein Sciences$Specializing in monoclonal, bispecific, and multi-specific antibodies, fusion-proteins, cytokines, enzymes, and other biologics, we offer our customers high productivity and high quality antibody and protein production services for all of your research needs.Protein SciencesSpecializing in monoclonal, bispecific, and multi-specific antibodies, fusion-proteins, cytokines, enzymes, and other biologics, we offer our customers high productivity and high quality antibody and protein production services for all of your research needs.Learn more Development$Utilizing one of the world’s largest and most experienced development teams, we have the resources, technologies and expertise to drive your program toward IND and BLA in the most efficient and cost-effective manner. Protein Sciences$We unite expert protein engineering capabilities with our high throughput and high productivity research-scale protein production services to enable all of your R&D initiatives.Protein SciencesWe unite expert protein engineering capabilities with our high throughput and high productivity research-scale protein production services to enable all of your R&D initiatives.Learn more Cell Line Engineering$Provided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading timelines for cell line engineering and strain development across a wide range of biotherapeutics.Cell Line EngineeringProvided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading timelines for cell line engineering and strain development across a wide range of biotherapeutics.Learn more Analytical Sciences$Our extensive analytical testing services offer top-tier expertise in method development for in-process, release, and stability assays, and support of cell line, process, and formulation development activities, product characterization, developability assessments and other key IND- and BLA-enabling studies.Analytical SciencesOur extensive analytical testing services offer top-tier expertise in method development for in-process, release, and stability assays, and support of cell line, process, and formulation development activities, product characterization, developability assessments and other key IND- and BLA-enabling studies.Learn more Process Development & Scale Up$Multiple upstream and downstream PD labs facilitate the establishment and scale-up of fed-batch, intensified fed-batch, and continuous manufacturing approaches for diverse biotherapeutic modalities in both early and late-stage development.Process Development & Scale UpMultiple upstream and downstream PD labs facilitate the establishment and scale-up of fed-batch, intensified fed-batch, and continuous manufacturing approaches for diverse biotherapeutic modalities in both early and late-stage development.Learn more Formulation & Drug Product Development$We provide advanced drug product development services spanning biologics, vaccines, and small molecules, with expertise in formulating clinical and commercial products in liquid, frozen, and lyophilized forms, compatible with various container closure systems such as vials, prefilled syringes, and other combination product types.Formulation & Drug Product DevelopmentWe provide advanced drug product development services spanning biologics, vaccines, and small molecules, with expertise in formulating clinical and commercial products in liquid, frozen, and lyophilized forms, compatible with various container closure systems such as vials, prefilled syringes, and other combination product types.Learn more Cell Banking & Characterization$Offering in-house, one-stop cell banking and cell line characterization services, compliant with global GMP regulations and ICH guidelines, we operate over 20 cGMP cell banking suites ensuring capacity availability and timely execution of this critical CMC development activity.Cell Banking & CharacterizationOffering in-house, one-stop cell banking and cell line characterization services, compliant with global GMP regulations and ICH guidelines, we operate over 20 cGMP cell banking suites ensuring capacity availability and timely execution of this critical CMC development activity.Learn more Viral Clearance$Our extensive experience and expertise, along with EMA, ISO (CNAS), and CMA-certified laboratories, and exceptional track record for IND- and BLA-enabling viral clearance study acceptance by global regulatory agencies, form the cornerstones for this pivotal aspect of any CMC development program.Viral ClearanceOur extensive experience and expertise, along with EMA, ISO (CNAS), and CMA-certified laboratories, and exceptional track record for IND- and BLA-enabling viral clearance study acceptance by global regulatory agencies, form the cornerstones for this pivotal aspect of any CMC development program.Learn more Regulatory Support$Our experienced regulatory affairs team supports drug filing and registration with over 370 INDs/CTAs, 20+ BLAs/MAAs/NDAs/EUAs, and 150 Module 3 CMC packages since 2015.Regulatory SupportOur experienced regulatory affairs team supports drug filing and registration with over 370 INDs/CTAs, 20+ BLAs/MAAs/NDAs/EUAs, and 150 Module 3 CMC packages since 2015.Learn more Manufacturing$Multiple state-of-the-art, premier quality cGMP clinical- and commercial-scale drug substance (DS) and drug product (DP) facilities across four countries for the production of a wide array of biologics from both mammalian and microbial expression systems. Clinical DS GMP Manufacturing$Operating multiple high-quality, state-of-the-art clinical-scale cGMP facilities for biologics drug substance (DS) production utilizing both mammalian and microbial expression systems.Clinical DS GMP ManufacturingOperating multiple high-quality, state-of-the-art clinical-scale cGMP facilities for biologics drug substance (DS) production utilizing both mammalian and microbial expression systems.Learn more Clinical DP GMP Manufacturing$Multiple, highly flexible clinical-scale drug product (DP) manufacturing facilities for the formulation, fill, labelling and packaging of biologics and parenterals under Current Good Manufacturing Practice (cGMP) conditions as defined by global regulatory agencies.Clinical DP GMP ManufacturingMultiple, highly flexible clinical-scale drug product (DP) manufacturing facilities for the formulation, fill, labelling and packaging of biologics and parenterals under Current Good Manufacturing Practice (cGMP) conditions as defined by global regulatory agencies.Learn more Commercial DS GMP Manufacturing$We provide a global dual source manufacturing network that employs multiple large-scale drug substance (DS) GMP manufacturing facilities for the production of biologics utilizing our world-class operations and regulatory agency-approved quality systems.Commercial DS GMP ManufacturingWe provide a global dual source manufacturing network that employs multiple large-scale drug substance (DS) GMP manufacturing facilities for the production of biologics utilizing our world-class operations and regulatory agency-approved quality systems.Learn more Commercial DP GMP Manufacturing$Multiple large-scale drug product (DP) manufacturing facilities located across the globe for the high-quality formulation, fill, labelling and packaging of biologics, parenterals and placebo into a wide array of container closure systems.Commercial DP GMP ManufacturingMultiple large-scale drug product (DP) manufacturing facilities located across the globe for the high-quality formulation, fill, labelling and packaging of biologics, parenterals and placebo into a wide array of container closure systems.Learn more Testing$We provide extensive expertise for in-process, characterization, release and stability method development and testing either in support of our integrated biologics development platforms or as standalone projects. Our wide-range of analytical and biosafety testing Centers of Excellence and regulatory agency-approved quality control (QC) laboratories are the backbone of every service we provide our clients. Biosafety Testing$High quality, in-house and EMA, ISO (CNAS) and CMA certified biosafety testing facilities for adventitious agent screening of raw materials, cell lines and unprocessed bulk along with our extensive viral clearance capabilities is available to provide our clients with a single-source biosafety testing service offering.Biosafety TestingHigh quality, in-house and EMA, ISO (CNAS) and CMA certified biosafety testing facilities for adventitious agent screening of raw materials, cell lines and unprocessed bulk along with our extensive viral clearance capabilities is available to provide our clients with a single-source biosafety testing service offering.Learn more Analytical Testing$We offer an extensive array of assay development and analytical testing services, including bioassay development and forensic investigation analysis, along with other key characterization and IND and BLA-enabling studies throughout the various phases of drug development – all tailored for your unique product and project needs.Analytical TestingWe offer an extensive array of assay development and analytical testing services, including bioassay development and forensic investigation analysis, along with other key characterization and IND and BLA-enabling studies throughout the various phases of drug development – all tailored for your unique product and project needs.Learn more Centers of Excellence (CoE)$Our CoEs support projects with specialized testing throughout the product lifecycle, expediting project timelines and ensuring analytical readiness for commercialization.Centers of Excellence (CoE)Our CoEs support projects with specialized testing throughout the product lifecycle, expediting project timelines and ensuring analytical readiness for commercialization.Learn more Global Quality Control (QC)$Regulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Global Quality Control (QC)Regulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Learn more Quality Quality & Regulatory$We provide world-class quality systems, harmonized across our global manufacturing sites and approved by multiple global regulatory agencies, including the U.S. FDA, EMA, NMPA, PMDA, MFDS, HSA, ANVISA and Health Canada for the production and testing of a wide array of biologics. Global Compliance$Oversees global quality system and audit, IT quality, internal compliance, and risk analytics functions. This team embeds quality and compliance across the entire organization to ensure the products we manufacture are of the highest efficacy and safety standards and in line with your expectations.Global ComplianceOversees global quality system and audit, IT quality, internal compliance, and risk analytics functions. This team embeds quality and compliance across the entire organization to ensure the products we manufacture are of the highest efficacy and safety standards and in line with your expectations.Learn more Quality Assurance$Global systems meet regulatory standards, ingrained commitment to quality from CEO to employees, harmonized QA across worldwide sites for biologics and vaccines production.Quality AssuranceGlobal systems meet regulatory standards, ingrained commitment to quality from CEO to employees, harmonized QA across worldwide sites for biologics and vaccines production.Learn more Quality Control$Regulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Quality ControlRegulatory compliant, in-house, QC labs support all clinical and commercial GMP sites pre- and post-production, ensuring top-quality testing for products and oversight of other critical functions (e.g., environmental monitoring, cleaning validations, instrument life-cycle and sample/retain management and audits).Learn more Regulatory Affairs$Our experienced regulatory affairs team supports our client’s CMC dossier, drug filing and registration needs. Since 2015 this team has supported 550+ INDs, CTAs, BLAs, MAAs, NDAs and EUAs, and written 200+ Module 3 CMC packages on behalf of our global clients.Regulatory AffairsOur experienced regulatory affairs team supports our client’s CMC dossier, drug filing and registration needs. Since 2015 this team has supported 550+ INDs, CTAs, BLAs, MAAs, NDAs and EUAs, and written 200+ Module 3 CMC packages on behalf of our global clients.Learn more Featured Platforms Integrated Platforms$Comprehensive, high-quality, end-to-end solutions driving efficiency, decreasing time to clinic and reducing project risks from concept to commercialization. Target to Lead$Providing expertise, highly efficient tailored solutions, state-of-the-art technologies and world-class facilities for the engineering, generation, and optimization of antibodies and other biologics from target identification to final lead selection.Target to LeadProviding expertise, highly efficient tailored solutions, state-of-the-art technologies and world-class facilities for the engineering, generation, and optimization of antibodies and other biologics from target identification to final lead selection.Learn more DNA to IND$Providing industry-leading 10-month (or less) DNA to IND timeline for biologics by leveraging our single-source, high-quality, and well-vetted development platform across all CMC activities.DNA to INDProviding industry-leading 10-month (or less) DNA to IND timeline for biologics by leveraging our single-source, high-quality, and well-vetted development platform across all CMC activities.Learn more IND to BLA$Streamlined late-phase development and manufacturing services, ensuring BLA filing in 15 months or less, with global commercialization support through our highly-vetted development platforms.IND to BLAStreamlined late-phase development and manufacturing services, ensuring BLA filing in 15 months or less, with global commercialization support through our highly-vetted development platforms.Learn more Discovery Technologies$A full spectrum of discovery services and technologies for the engineering, generation, characterization, optimization and selection of high-potency novel antibody therapeutics. Bispecific & Multispecific Antibodies – WuXiBody™$The WuXiBody™ platform for the generation of bispecific (bsAb) and multispecific (msAb) antibodies speeds up drug development by 6-18 months, cuts production costs, and enables flexible assembly of mAb sequence pairs into various formats with different valency.Bispecific & Multispecific Antibodies - WuXiBody™The WuXiBody™ platform for the generation of bispecific (bsAb) and multispecific (msAb) antibodies speeds up drug development by 6-18 months, cuts production costs, and enables flexible assembly of mAb sequence pairs into various formats with different valency.Learn more Advanced Hybridoma Platform – WuXiHybrid™$Using advanced technologies to generate diverse monoclonal antibodies (mAb) for various targets. Our experienced scientists overcome technical challenges to deliver high-quality mAbs to our clients worldwide.Advanced Hybridoma Platform - WuXiHybrid™Using advanced technologies to generate diverse monoclonal antibodies (mAb) for various targets. Our experienced scientists overcome technical challenges to deliver high-quality mAbs to our clients worldwide.Learn more Naive Phage Display Library – WuXiLiAb™$Offering high-quality phage display library construction and customized library selection and screening services via our WuXiLiAb® human naïve / synthetic phage display libraries, VHH naïve / humanized VHH synthetic libraries and antibody immune libraries.Naive Phage Display Library - WuXiLiAb™Offering high-quality phage display library construction and customized library selection and screening services via our WuXiLiAb® human naïve / synthetic phage display libraries, VHH naïve / humanized VHH synthetic libraries and antibody immune libraries.Learn more VHH-based Multispecific Antibody Platform – SDARBody™$Novel technology platform to enable the development of multispecific proteins. Highly flexible platform capable of generating multispecific antibody and protein therapeutics with high affinity, low immunogenicity risk and excellent developability characteristics.VHH-based Multispecific Antibody Platform - SDARBody™Novel technology platform to enable the development of multispecific proteins. Highly flexible platform capable of generating multispecific antibody and protein therapeutics with high affinity, low immunogenicity risk and excellent developability characteristics.Learn more ScFv-based BsAb & MsAb Antibody Platform – SKYBody™$An innovative scFv (single-chain fragment variables)-based platform for the generation of bispecific or multispecific antibodies from nearly any sequence pair. The platform significantly improves scFv stability providing bsAbs and msAbs with strong developability characteristics.ScFv-based BsAb & MsAb Antibody Platform - SKYBody™An innovative scFv (single-chain fragment variables)-based platform for the generation of bispecific or multispecific antibodies from nearly any sequence pair. The platform significantly improves scFv stability providing bsAbs and msAbs with strong developability characteristics.Learn more VAST-B Single B-Cell Antibody Discovery Platform$An advanced, high speed, high throughput and high resolution antibody screening strategy using Beacon® technology for the rapid discovery of monoclonal antibodies (mAb) from any host species.VAST-B Single B-Cell Antibody Discovery PlatformAn advanced, high speed, high throughput and high resolution antibody screening strategy using Beacon® technology for the rapid discovery of monoclonal antibodies (mAb) from any host species.Learn more Development Technologies$Cutting-edge bioprocessing platforms and technologies designed to enable high-quality biologics to enter clinical trials faster, more efficiently and more cost-effectively. Ultra-Intensified Fed-batch platform – WuXiUI™$Ultra-intensified fed-batch bioprocessing platform utilizes an intermittent perfusion approach to achieve 3-6-fold higher productivity and 60 – 80% reduction in manufacturing cost of goods compared to traditional fed-batch processes.Ultra-Intensified Fed-batch platform - WuXiUI™Ultra-intensified fed-batch bioprocessing platform utilizes an intermittent perfusion approach to achieve 3-6-fold higher productivity and 60 – 80% reduction in manufacturing cost of goods compared to traditional fed-batch processes.Learn more Rapid Research Material Generation – WuXian™$Custom protein generation services, producing high-quality, research-grade proteins/antibodies by using our industry-leading team of cell culture, purification and analytical experts and high-throughput, cost-effective production technologies.Rapid Research Material Generation - WuXian™Custom protein generation services, producing high-quality, research-grade proteins/antibodies by using our industry-leading team of cell culture, purification and analytical experts and high-throughput, cost-effective production technologies.Learn more Cell Line Development – WuXia™$Proven, high-yielding (up to 11 g/L) and high-quality cell line development platform, accepted by regulatory agencies worldwide.Cell Line Development - WuXia™Proven, high-yielding (up to 11 g/L) and high-quality cell line development platform, accepted by regulatory agencies worldwide.Learn more Continuous Bioprocessing – WuXiUP™$This ultra-high productivity continuous bioprocessing platform, achieves 5-15X greater productivity, delivering high-yield, quality drug products with flexibility and cost-effectiveness through intensified perfusion culture, continuous harvest and optional downstream continuous product capture step.Continuous Bioprocessing - WuXiUP™This ultra-high productivity continuous bioprocessing platform, achieves 5-15X greater productivity, delivering high-yield, quality drug products with flexibility and cost-effectiveness through intensified perfusion culture, continuous harvest and optional downstream continuous product capture step.Learn more ADC Development Platform – WuXiDAR4™$Our drug-to-antibody ratio and enrichment technology greatly enhances DAR4 (four payload molecules per mAb) percentage in the final ADC product and improves conjugation efficiency.ADC Development Platform - WuXiDAR4™Our drug-to-antibody ratio and enrichment technology greatly enhances DAR4 (four payload molecules per mAb) percentage in the final ADC product and improves conjugation efficiency.Learn more High Concentration & HTP DP Platform – WuXiHigh™$Advanced high throughput formulation platform for development of high concentration biologics drug products using distinctive viscosity reducers and synergistic excipient combinations to enhance formulation stability and reduce viscosity.High Concentration & HTP DP Platform - WuXiHigh™Advanced high throughput formulation platform for development of high concentration biologics drug products using distinctive viscosity reducers and synergistic excipient combinations to enhance formulation stability and reduce viscosity.Learn more Manufacturing Technologies$Advanced biomanufacturing platforms empower our global healthcare partners to deliver biologics to the clinic and on to the market for the benefit of patients worldwide. Single-Use Bioreactors$We operate several of the world’s largest single-use bioreactor facilities for biologics manufacturing, leveraging the risk reduction, flexibility, cost-effectiveness, and eco-friendliness offered by these systems.Single-Use BioreactorsWe operate several of the world’s largest single-use bioreactor facilities for biologics manufacturing, leveraging the risk reduction, flexibility, cost-effectiveness, and eco-friendliness offered by these systems.Learn more Scale-Out Biomanufacturing$Helping to pioneer this biomanufacturing strategy for higher volume production, we can help you reduce risk and increase manufacturing flexibility across the entire product lifecycle by using multiple, same-scale bioreactors to meet clinical and market demand.Scale-Out BiomanufacturingHelping to pioneer this biomanufacturing strategy for higher volume production, we can help you reduce risk and increase manufacturing flexibility across the entire product lifecycle by using multiple, same-scale bioreactors to meet clinical and market demand.Learn more Robotic Aseptic Filling$Reducing manufacturing risk through the use of this fully programmable, robotic, gloveless, isolator-based technology for advanced aseptic drug product fill processing. These systems provide extensive flexibility to support complex fills across a wide range of biologics and container closure systems.Robotic Aseptic FillingReducing manufacturing risk through the use of this fully programmable, robotic, gloveless, isolator-based technology for advanced aseptic drug product fill processing. These systems provide extensive flexibility to support complex fills across a wide range of biologics and container closure systems.Learn more Continuous Manufacturing Process$Combining intensified perfusion culture (IPC) and continuous direct product capture (CDPC), and advanced equipment for increased productivity and cost reduction.Continuous Manufacturing ProcessCombining intensified perfusion culture (IPC) and continuous direct product capture (CDPC), and advanced equipment for increased productivity and cost reduction.Learn more Animal Health Technologies$One-stop solution for superior animal health outcomes. Animal Health Technologies$We offer CMC-compliant, one-stop solution for animal health, to support taking drug substance and drug product from research to manufacturing.Animal Health TechnologiesWe offer CMC-compliant, one-stop solution for animal health, to support taking drug substance and drug product from research to manufacturing.Learn more Sustainability Sustainability Environmental Social Governance ESG Latest News ESG Report Careers What We Value Proud Life Meet our people Experienced Professionals Employee Stories Worldwide Join us Job Opportunity Talent Pool Investors Corporate Governance Financial Reports Announcements & Circulars Stock Information Investor Events Presentations & Webcasts Calendar Investor Day Investors Contact News & Resources Press Releases Knowledge Center Events Contact Us LinkedIn YouTube Twitter info@wuxibiologics.com CRDMO Offering End-to-End Solutions Learn More Discovery From Target to Drug Candidate Learn More Development 10 Months from DNA to IND Learn More Manufacturing Global Dual Sourcing Learn More Vision & Mission Culture History & Awards Business Ethics ESG Services & Capabilities A global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics. Production Systems Industry leading end-to-end services for a wide-range of biologics produced via either mammalian or microbial production systems. Learn more. Capabilities Unparalleled capacities, expertise and single-source solutions from drug concept to commercialization. Learn more. Quality World-class quality systems meeting global standards and approved by regulatory agencies worldwide. Learn more. Featured Platforms Integrated programs and advanced technologies to streamline and reduce the costs of drug development. Learn more. Locations As a leading global CRDMO, with over 12,000 skilled employees in the United States, Ireland, Germany, China and Singapore, WuXi Biologics provides an extensive R&D and manufacturing network to support our clients worldwide. United States Massachusetts U.S. 189,500sq.ft. Capacity of36,000L L‌earn M‌ore New Jersey U.S. 154,400sq.ft. Operations2021 L‌earn M‌ore Pennsylvania U.S. 33,000sq.ft. Operations2020 L‌earn M‌ore BostonU.S. Research Service Center Operational since2023 L‌earn M‌ore Ireland Dundalk Ireland 2.79 millionsq.ft. Operations2022 L‌earn M‌ore WuXi Vaccines Ireland $240Million investment Operations2022 L‌earn M‌ore Germany Leverkusen Germany 130,000+sq.ft. Operations2020 L‌earn M‌ore Wuppertal Germany 322,000sq.ft. Operations2021 L‌earn M‌ore Singapore Singapore Integrated CRDMO center Operational2026 L‌earn M‌ore China Shanghai Waigaoqiao Free Trade Zone 200,000sq.ft. Operations2018 L‌earn M‌ore Shanghai Fengxian District 1.6 millionsq.ft. Operations2021 L‌earn M‌ore Shanghai Lin-gang Special Area 86,000+sq.ft. Operations2022 L‌earn M‌ore Wuxi 1.72 millionsq.ft. Operations2012 L‌earn M‌ore Suzhou 170,000sq.ft. Operations2014 L‌earn M‌ore Hangzhou 370,000sq.ft. Operations2020 L‌earn M‌ore Chengdu 314,000sq.m. Capacity of48,000L L‌earn M‌ore Shijiazhuang 880,000sq.ft. Operations2022 L‌earn M‌ore Hangzhou 530,000sq.ft. Operations2021 L‌earn M‌ore Suzhou 123,000sq.ft. Operations2017 L‌earn M‌ore World-class Quality We provide quality assurance, quality control and operational systems that meet or exceed worldwide regulatory standards. Our premier world-class quality systems have been approved by multiple global regulatory agencies for a wide variety of biologics and vaccines. L‌earn M‌ore As of Jun, 2024 15 GMP Facilities Certified 21 Audits from Different Global Regulatory Agencies 37 Successful Regulatory Agency Inspections 1400 + Successful Client Quality Audits Culture Integrity, Dedication, Working Together & Sharing Success Put Customers First Exceed customers’ expectations, maximize the value for our customers, and win customers’ loyalty with a 100% customer retention rate. Demonstrate Integrity Take the initiative to promote a positive work environment where doing the right thing is the standard. Be positive and enthusiastic, approach challenges with energy and optimism. Strive for Excellence Pursue focus and expertise, and optimize processes in order to deliver excellent results. Relentlessly drive learning, accumulation, improvement and innovation. Execute for Results Drive effective execution of each project and objective, focusing on solutions and results. Pursue Collaboration and Teamwork Engage in collaboration and mutual development with an open and win-win mindset by sharing resources and leveraging the complementary advantages of each. Embrace Change and Drive Innovation Demonstrate flexibility and ability to embrace change. Adapt quickly to transformational and innovative conditions with a strong commitment to breakthroughs and development. Environmental Social Governance (ESG) We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, reducing our environmental footprint, advocating reduced energy consumption, minimizing effluent, and acting responsibly to reduce operational impact on the environment. L‌earn M‌ore Careers WuXi Biologics offers exciting job opportunities and careers around the globe. Come be a part of our PROUD (Passion, Reward, Ownership, Unity & Determination) culture and embrace the challenges and new opportunities as we work together to enable our clients and benefit patients worldwide. L‌earn M‌ore Subscribe to our Newsletter Stay up-to-date on our latest news, financial results and capabilities at our sites around the globe! Subscribe Now Latest News L‌earn M‌ore News Aug. 30, 2024 WuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUITM in 2,000L GMP Manufacturing Finance Aug. 21, 2024 WuXi Biologics Reports Solid 2024 Interim Results News Aug. 08, 2024 WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers Learn More About WuXi Biologics Contact General Inquiries Newsletter Sign-Up Join Us Compliance Reporting ESG Services & Capabilities Production Systems Capabilities Quality Featured Platforms Company About Us Sustainability Careers Investors News & Media Terms of Use  |   Privacy Policy  |   Cookie Policy Copyright © 2024 WuXi Biologics. All Rights Reserved. 苏ICP备16033595号 苏公网安备 32021102001100号 We use cookies that are necessary for our website to function properly. We also use cookies to retain user preferences, for analysing our website traffic and for statistical and web-traffic marketing purposes. By clicking “accept all”, you provide your specific and active consent for the use of last-mentioned categories of cookies. To see a list of the cookies and their purpose, click here. Please see section 6 in our Privacy Policy for more information on (i) how we use cookies and (ii) your rights and actions in relation to data protection. Accept All1727046011https://wuxibiologics.com

ཁྱོད་རའི་ས་ཁོངས་ཞུན་དག་འབད་ག?

ཁྱོད༌ག༌ཅི༌འབདཝ༌སྨོ?